Navigation Links
Modified Insulin Most Effective For Controlling Post-Meal Blood Sugar Levels
Date:9/15/2008

ROCKVILLE, Md., Sept. 15 /PRNewswire-USNewswire/ -- Pre-mixed insulin analogues, a modified form of conventional pre-mixed human insulin, are more effective than long-acting analogues for controlling high blood sugar levels after meals in patients with type 2 diabetes, according to a report funded by the Agency for Healthcare Research and Quality, part of the U.S. Department of Health and Human Services.

Conventional pre-mixed human insulin, however, appears to be equally effective as pre-mixed insulin analogues for lowering blood sugar levels when patients go eight or more hours without eating, according to the report. A version of the analysis is available on-line in the Annals of Internal Medicine.

Type 2 diabetes accounts for more than 90 percent of diabetes. The number of Americans diagnosed with type 2 diabetes tripled from 5.6 million in 1980 to 15.8 million in 2005. Obesity increases the risks of developing type 2 diabetes. Diabetes can cause serious problems with the heart, kidneys, eyes and nerves. Many patients with type 2 diabetes control their blood sugar through diet and use of oral medications. Recent research suggests that good blood glucose control can reduce loss of sight, kidney failure, and heart disease.

The new report was compiled by the Johns Hopkins University Evidence-based Practice Center in Baltimore, one of 14 such centers that are funded by AHRQ through its Effective Health Care program. The report represents a systematic review of 45 research studies and is intended to provide unbiased, evidence-based information so that patients, clinicians and others can make the best possible treatment decisions.

"While it is clear that pre-mixed insulin analogues offer certain advantages to patients with diabetes, what is good for one patient may not be good for another," said AHRQ Director Carolyn M. Clancy, M.D. "This report offers an important reminder that patients with diabetes should review their treatment pl
'/>"/>

SOURCE Agency for Healthcare Research & Quality
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
2. Sanofi Aventis: People With Type 2 Diabetes Treated With LANTUS(R) and APIDRA(R) Achieved Greater Reductions in A1C Than Those Treated With Pre-mixed Insulin
3. Oramed Pharmaceuticals Chosen to Present Oral Insulin Trial Results at EASD Conference (September 7-11, Rome)
4. Insulin Analogues From Novo Nordisk, Eli Lilly and Sanofi-Aventis Will Drive Growth in the Type 1 Diabetes Drug Market
5. Nature Publication Reports on Key Role of Bile Acids in Glucose Metabolism and Insulin Signaling
6. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
7. Oramed Pharmaceuticals Announces Successful Phase 2A Clinical Trial of its Oral Insulin Capsule
8. Treatment Corrects Severe Insulin Imbalance in Animal Studies
9. Oramed Pharmaceuticals to Hold Conference Call on August 6 to Present Results of Phase 2A Oral Insulin Capsule Clinical Trials
10. Newly Published Study Results Showed That Two Mealtime Insulin Dosing Algorithms Were Effective for Patients with Type 2 Diabetes
11. Emisphere Announces Data From Independent Clinical Study of Effects of Oral GLP-1 on Glucose and Insulin Concentrations
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2009).../ -- Calixa Therapeutics Inc. today announced the ...in patients with complicated urinary tract infecti...cephalosporin antibiotic with excellent in vitro ...inosa , including drug resistant isolates. Calixa... for serious bacterial infections in hospitalized ...
(Date:6/29/2009)...Biotherapeutics Based On Naturally Resected tRNA S... -- Pangu BioPharma, a subsidiary of aTyr Pharma i...rd patent application on proprietary, naturally oc...h tRNA synthetases are universal and essential com...l organisms, human synthetases have naturally occu...
(Date:6/26/2009)...OSAKA, Japan, June 27, 2009 Takeda...nnounced that Takeda Global Research & Develop....S.) subsidiary received on June 26 (U.S. time) a ...ug Administration (FDA) regarding the Company,s Ne...ve dipeptidyl peptidase IV (DPP-4) inhibitor under...
(Date:6/25/2009)...perts Slated to Attend First National Symposium - ... first national symposium designed to explore the ...week in New York City when thirteen top experts ga...espective fields. The SUNY Youth Sports Institute...h impacts that the $5 billion-a-year energy drink ...
Breaking Medicine Technology:Calixa Therapeutics Announces Initiation of Phase 2 Clinical Trial of Its Antibiotic, CXA-101, in Patients with Complicated Urinary Tract Infections 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 2Pangu BioPharma, aTyr Pharma's Subsidiary in Hong Kong, Files Three Patent Applications 3Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4Sunnylife Global Retains The Blaine Group For Investor Relations Financial Public Relations 2489 1Sunnylife Global Retains The Blaine Group For Investor Relations Financial Public Relations 2489 2Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2485 1Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2485 2Wedgewood Pharmacy and Midwest Veterinary Supply Sign New Agency Agreement 2485 3In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Span 2481 1In Honor of Hispanic Heritage Month and Spanish Speakers Worldwide International Hyperhidrosis Society Publishes Important New Patient Booklet in Span 2481 2Book on weeds and invasive plants discusses how to manage them using ecological approaches 620 1Book on weeds and invasive plants discusses how to manage them using ecological approaches 620 2Book on weeds and invasive plants discusses how to manage them using ecological approaches 620 3
...E)--Mar 20, 2007 - Arrowhead,Research Corporation ...subsidiary Calando Pharmaceuticals has published,r...of Sciences,(PNAS) of the first non-human primate ...o,s lead siRNA therapeutic candidate., Calando is ...ymeric delivery systems and siRNA design to create...
...tem, dermal patch and a direct,current power sou...LE, March 20, 2007 /PRNewswire/ -- Dharma Therapeu...l drug delivery company,and wholly owned subsidi..., Tokyo, Japan announced that its active transderm...ine and epinephrine,through the skin via a mild ...
Other Medicine Technology:Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 2Arrowhead Subsidiary, Calando Pharmaceuticals Publishes Study on,Targeted, Systemic Delivery of siRNA 3Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 2Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain,Associated With Insertion of an Intravenous Catheter in Their Phase,2 Clinical Trial 3
(Date:7/3/2009)... July 3 Bertalan Mesko, medical bl...e e-guide for medical professionals focusing on ...dical conferences are expensive and patients are a...is eGuide helps doctors enter a virtual realm and ...ee as Second Life provides opportunities for case ...
(Date:7/3/2009)... Republicans on the Sen...health care reform legislation that would eliminat... many women could lose coverage for abortion servi...s. Plus, millions of uninsured women will still la... promised a better quality of life. , , If thes...
(Date:7/3/2009)... ReverseAges.com launches new content to includ...atigue, and how to best deal with these health iss...EB) July 3, 2009 -- ReverseAges.com has recently l... the dangers of common health issues such as high ... variety of factors, and the new content on Revers...
(Date:7/2/2009)...ore,s Bioprocessing Technology Institute (BTI) hav...apoptosis inhibitory molecule" (FAIM), protects bo...ammed cell death. , Their research is published...ation . , The scientists, Jianxin Huo, Ph.D., an...cess may possibly be manipulated for clinical appl...
Breaking Medicine News(10 mins):Health News:Gene's novel role may provide key to treating liver and neurodegenerative diseases 2
...that practitioners don’t have to use a lot of forc...ponse // as the body has its own energy or "biomag... system. That field can be altered by acupuncture ...opathy, massage, and even by the therapists' own p...
...e might be another use for cell phones that come c...ations.// Swiss researchers who used the phone cam...remote locations say doctors felt fairly comfortab...s. The study involved 52 patients with 61 chronic ...
...tudy researchers say a three-day regimen of the an...t as effective // as ciprofloxacin (Cipro) at trea...The most common bacterial infections for women are...tions. Treating the problem has become increasingl...
... now that after delivery depressions, that had pla... due to the trauma of the delivery. As a result of...ned caesarian birth to avoid the depression. A new... British Medical Journal says that this may not be...
Other Medicine News:
Double round silicone drain with trocar, 49 in. long, with 12.25 in. (30.5 cm) hole pattern
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe.
Used for percutaneous placement of laparoscopic surgical instruments. Check-Flo® valve provides a secure seal around the instruments to be introduced. Supplied sterile in peel-open packages. Inte
Used for cholangiography and bile stone removal using fluoroscopy. Dual lumen catheter design allows concomitant fluoroscopic biliary imaging and wire basket placement for stone extraction. Supplied
Medicine Products: